Vanguard Investments Australia
TERN

Vanguard Investments Australia’s Terns Pharmaceuticals TERN Stock Holding History

Vanguard Investments Australia’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,604
Closed -$770K – 2422
2026
Q1 		$770K Buy
+14,604
New +$600K ﹤0.01% 1347

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Investments Australia's TERN Position: Q2 2026 in Review

Vanguard Investments Australia sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 14,604 shares — an estimated $770K sold.

Vanguard Investments Australia first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $770K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Vanguard Investments Australia reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Investments Australia sold 14,604 Terns Pharmaceuticals shares in Q2 2026, an estimated $770K.
  • Vanguard Investments Australia first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Investments Australia's Terns Pharmaceuticals position peaked at $770K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.